Potential role of the cannabinoid receptor CB in the pathogenesis of erosive and nonerosive gastro-oesophageal reflux disease. (abst – 2010) http/www.ncbi.nlm.nih.gov/pubmed/20497140
Beyond acid suppression: new pharmacologic approaches for treatment of GERD. (abst – 2010) http/www.ncbi.nlm.nih.gov/pubmed/20425477
The Gastrointestinal Pharmacology of Cannabinoids: Focus on Motility. (full – 2012) http/content.karger.com/produktedb/produkte.asp?DOI=000339072&typdf
Localization of mGluR5, GABA(B) , GABA(A) , and cannabinoid receptors on the vagovagal reflex pathway responsible for transient lower esophageal sphincter relaxation in humans: an immunohistochemical study. (full – 2012) http/onlinelibrary.wiley.com/doi/10.1111/j.1365-2982.2011.01868.x/full
Discovery of agonists of cannabinoid receptor 1 with restricted CNS penetration aimed for treatment of gastroesophageal reflux disease. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/23227781
Potential therapeutic applications of cannabinoids in gastrointestinal and liver diseases: Focus on Δ9-tetrahydrocannabinol pharmacology (abst – 2014) http/onlinelibrary.wiley.com/doi/10.1002/9781118451281.ch7/summary
(Mo1121) Cannabinoid Use Decreases ED Utilization in a Gastroenterology Clinic Population (abst – 2014) http/www.gastrojournal.org/article/S0016-5085%2814%2962037-0/pdf
Beyond acid suppression: new pharmacologic approaches for treatment of GERD. (abst – 2010) http/www.ncbi.nlm.nih.gov/pubmed/20425477
The Gastrointestinal Pharmacology of Cannabinoids: Focus on Motility. (full – 2012) http/content.karger.com/produktedb/produkte.asp?DOI=000339072&typdf
Localization of mGluR5, GABA(B) , GABA(A) , and cannabinoid receptors on the vagovagal reflex pathway responsible for transient lower esophageal sphincter relaxation in humans: an immunohistochemical study. (full – 2012) http/onlinelibrary.wiley.com/doi/10.1111/j.1365-2982.2011.01868.x/full
Discovery of agonists of cannabinoid receptor 1 with restricted CNS penetration aimed for treatment of gastroesophageal reflux disease. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/23227781
Potential therapeutic applications of cannabinoids in gastrointestinal and liver diseases: Focus on Δ9-tetrahydrocannabinol pharmacology (abst – 2014) http/onlinelibrary.wiley.com/doi/10.1002/9781118451281.ch7/summary
(Mo1121) Cannabinoid Use Decreases ED Utilization in a Gastroenterology Clinic Population (abst – 2014) http/www.gastrojournal.org/article/S0016-5085%2814%2962037-0/pdf